These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 36691322)
1. Circ_0110498 facilitates the cisplatin resistance of non-small cell lung cancer by mediating the miR-1287-5p/RBBP4 axis. Hao D; Li Y; Shi J; Jiang J Thorac Cancer; 2023 Mar; 14(7):662-672. PubMed ID: 36691322 [TBL] [Abstract][Full Text] [Related]
2. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948 [TBL] [Abstract][Full Text] [Related]
3. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer. Chang F; Li J; Sun Q; Wei S; Song Y Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543 [TBL] [Abstract][Full Text] [Related]
4. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement. Chen H; Li F; Xue Q Bioengineered; 2022 Feb; 13(2):2828-2840. PubMed ID: 35068326 [TBL] [Abstract][Full Text] [Related]
5. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072 [TBL] [Abstract][Full Text] [Related]
7. Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating Wang X; Wang H; Jiang H; Qiao L; Guo C Cancer Biother Radiopharm; 2023 Jun; 38(5):293-304. PubMed ID: 34339285 [No Abstract] [Full Text] [Related]
8. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0102231 sponges miR-145 to promote non-small cell lung cancer cell proliferation by up-regulating the expression of RBBP4. Cao X; Li F; Shao J; Lv J; Chang A; Dong W; Zhu F J Biochem; 2021 Feb; 169(1):65-73. PubMed ID: 33084863 [TBL] [Abstract][Full Text] [Related]
10. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis. Xie H; Yao J; Wang Y; Ni B Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477 [TBL] [Abstract][Full Text] [Related]
11. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p. Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer. Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347 [TBL] [Abstract][Full Text] [Related]
13. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5). Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis. Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer. Pang J; Ye L; Zhao D; Zhao D; Chen Q Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744 [TBL] [Abstract][Full Text] [Related]
16. Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing KLF8 in a miR-198-dependent manner in non-small cell lung cancer. Li Y; Yang X; Xiong X Genomics; 2022 Mar; 114(2):110294. PubMed ID: 35134495 [TBL] [Abstract][Full Text] [Related]
17. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis. Liu Y; Zhai R; Hu S; Liu J Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608 [TBL] [Abstract][Full Text] [Related]
18. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2. Liu Y; Zhang Y; Li Q; Xu R; Huang N Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of METTL14-mediated m Gong S; Wang S; Shao M J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154 [TBL] [Abstract][Full Text] [Related]
20. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells. Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]